[1]Wang,Tao;Zhang,Zhongxing;Wallace,OwenB.;Deshpande,Milind;Fang,Haiquan;Yang,Zheng;Zadjura,LisaM.;Tweedie,DonaldL.;Huang,Stella;Zhao,Fang;Ranadive,Sunanda;Robinson,BrettS.;Gong,Yi-Fei;Ricarrdi,Keith;Spicer,TimothyP.;Deminie,Carol;Rose,Ronald;Wang,Hwei-GeneHeidi;Blair,WadeS.;Shi,Pei-Yong;Lin,Pin-Fang;Colonno,RichardJ.;Meanwell,NicholasA.[JournalofMedicinalChemistry,2003,vol.46,#20,p.4236-4239]
[2]Wang,Jingsong;Le,Nhut;Heredia,Alonso;Song,Haijing;Redfield,Robert;Wang,Lai-Xi[OrganicandBiomolecularChemistry,2005,vol.3,#9,p.1781-1786]
[1]Wang,Jingsong;Le,Nhut;Heredia,Alonso;Song,Haijing;Redfield,Robert;Wang,Lai-Xi[OrganicandBiomolecularChemistry,2005,vol.3,#9,p.1781-1786]
[2]Wang,Tao;Zhang,Zhongxing;Wallace,OwenB.;Deshpande,Milind;Fang,Haiquan;Yang,Zheng;Zadjura,LisaM.;Tweedie,DonaldL.;Huang,Stella;Zhao,Fang;Ranadive,Sunanda;Robinson,BrettS.;Gong,Yi-Fei;Ricarrdi,Keith;Spicer,TimothyP.;Deminie,Carol;Rose,Ronald;Wang,Hwei-GeneHeidi;Blair,WadeS.;Shi,Pei-Yong;Lin,Pin-Fang;Colonno,RichardJ.;Meanwell,NicholasA.[JournalofMedicinalChemistry,2003,vol.46,#20,p.4236-4239]
[1]Wang,Tao;Zhang,Zhongxing;Wallace,OwenB.;Deshpande,Milind;Fang,Haiquan;Yang,Zheng;Zadjura,LisaM.;Tweedie,DonaldL.;Huang,Stella;Zhao,Fang;Ranadive,Sunanda;Robinson,BrettS.;Gong,Yi-Fei;Ricarrdi,Keith;Spicer,TimothyP.;Deminie,Carol;Rose,Ronald;Wang,Hwei-GeneHeidi;Blair,WadeS.;Shi,Pei-Yong;Lin,Pin-Fang;Colonno,RichardJ.;Meanwell,NicholasA.[JournalofMedicinalChemistry,2003,vol.46,#20,p.4236-4239]
[1]Wang,Tao;Zhang,Zhongxing;Wallace,OwenB.;Deshpande,Milind;Fang,Haiquan;Yang,Zheng;Zadjura,LisaM.;Tweedie,DonaldL.;Huang,Stella;Zhao,Fang;Ranadive,Sunanda;Robinson,BrettS.;Gong,Yi-Fei;Ricarrdi,Keith;Spicer,TimothyP.;Deminie,Carol;Rose,Ronald;Wang,Hwei-GeneHeidi;Blair,WadeS.;Shi,Pei-Yong;Lin,Pin-Fang;Colonno,RichardJ.;Meanwell,NicholasA.[JournalofMedicinalChemistry,2003,vol.46,#20,p.4236-4239]
[1]Wang,Tao;Zhang,Zhongxing;Wallace,OwenB.;Deshpande,Milind;Fang,Haiquan;Yang,Zheng;Zadjura,LisaM.;Tweedie,DonaldL.;Huang,Stella;Zhao,Fang;Ranadive,Sunanda;Robinson,BrettS.;Gong,Yi-Fei;Ricarrdi,Keith;Spicer,TimothyP.;Deminie,Carol;Rose,Ronald;Wang,Hwei-GeneHeidi;Blair,WadeS.;Shi,Pei-Yong;Lin,Pin-Fang;Colonno,RichardJ.;Meanwell,NicholasA.[JournalofMedicinalChemistry,2003,vol.46,#20,p.4236-4239]
Title: Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors.
Journal: ACS medicinal chemistry letters 20160310
Title: Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores.
Journal: Bioorganic & medicinal chemistry letters 20130101
Title: Inhibitors of HIV-1 attachment. Part 11: the discovery and structure-activity relationships associated with 4,6-diazaindole cores.
Journal: Bioorganic & medicinal chemistry letters 20130101
Title: Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
Journal: Chemical biology & drug design 20121201
Title: An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors.
Journal: PloS one 20110101
Title: Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.
Journal: Bioorganic & medicinal chemistry letters 20101115
Title: Protection against HIV-envelope-induced neuronal cell destruction by HIV attachment inhibitors.
Journal: Archives of virology 20100501
Title: Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects.
Journal: Journal of medicinal chemistry 20091210
Title: An antibody-recruiting small molecule that targets HIV gp120.
Journal: Journal of the American Chemical Society 20091118
Title: Heterobiaryl human immunodeficiency virus entry inhibitors.
Journal: Journal of medicinal chemistry 20090723
Title: Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
Journal: Antimicrobial agents and chemotherapy 20080101
Title: Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.
Journal: Retrovirology 20080101
Title: Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.
Journal: Journal of medicinal chemistry 20071227
Title: Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Journal: Virology 20070801
Title: Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry.
Journal: Journal of separation science 20070601
Title: Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1.
Journal: Antimicrobial agents and chemotherapy 20061001
Title: Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
Journal: Biochemistry 20060912
Title: Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics simulation.
Journal: Biochimica et biophysica acta 20060401
Title: Inhibition of virus entry: an antiviral mechanism of emerging prominence.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060201
Title: Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Journal: Nature 20051103
Title: Drug firms donate compounds for anti-HIV gel.
Journal: Nature 20051103
Title: Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120.
Journal: Organic & biomolecular chemistry 20050507
Title: Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20040406
Title: Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions.
Journal: Journal of virology 20031001
Title: Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
Journal: Journal of medicinal chemistry 20030925
Title: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20030916
Title: Wang T, et al. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo,3-bpyridin-3-yl)oxoacetyl-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. J Med Chem. 2003 Sep 25;46(20):4236-9.
Title: Ho HT, et al. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events. J Virol. 2006 Apr;80(8):4017-25.
Title: Guo Q, et al. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions. J Virol. 2003 Oct;77(19):10528-36
